Evidence map›Paper›PMID 40115167›Full record

ArticleHead and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings2025

Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.

Kareem A Wahid, Cem Dede, Dina M El-Habashy, Serageldin Kamel, Michael K Rooney, Yomna Khamis, Moamen R A Abdelaal, Sara Ahmed, Kelsey L Corrigan, Enoch Chang and 14 more

Abstract read
In one paragraph

Article in Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Enhancing Head and Neck Tumor Segmentation in MRI: The Impact of Image Preprocessing and Model Ensembling.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025
    Article
  7. Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Kareem A WahidDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0002-0503-0175
Cem DedeDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0002-0543-9325
Dina M El-HabashyDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0001-5182-9976
Serageldin KamelDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0002-0046-4337
Michael K RooneyDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0002-2860-4653
Yomna KhamisDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0001-8531-0849
Moamen R A AbdelaalDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0003-4476-2122
Sara AhmedDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0002-1791-8366
Kelsey L CorriganDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0003-0314-6972
Enoch ChangDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0002-2879-5445
Stephanie O DudzinskiDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0001-9222-472X
Travis C SalzilloDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0001-6271-9879
Brigid A McDonaldDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0003-4230-1330
Samuel L MulderDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0001-5185-4805
Lucas McCullumDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0001-9788-7987
Qusai AlakaylehDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0009-0005-0050-6567
Carlos SjogreenDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0002-6584-7670
Renjie HeDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0001-9166-6286
Abdallah S R MohamedDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0003-2064-7613
Stephen Y LaiDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0001-8301-7286
John P ChristodouleasElekta, Atlanta, GA, USA.ORCID 0000-0001-5061-2038
Andrew J SchaeferDepartment of Computational Applied Mathematics and Operations Research, Rice University, Houston, TX, USA.ORCID 0000-0002-0379-741X
Mohamed A NaserDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0003-1020-4966
Clifton D FullerDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, TX, USA.ORCID 0000-0002-5264-3994

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck CancerR01CA257814 · NCI · RICE UNIVERSITY · PI FULLER, CLIFTON DAVID, SCHAEFER, ANDREW J · 2021 to 2024
$1.8M
Image Guided Cancer Therapy Training ProgramT32CA261856 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kristy Brock, Clifton David Fuller · 2022 to 2026
$1.2M
Probabilistic Deep Learning Cervical Lymph-Node Auto-Segmentation For Imaging-enhanced Evaluation of Extracapsular Extension Risk (PDL-CLASIFIER)R03DE033550 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FULLER, CLIFTON DAVID, NASER, MOHAMED · 2024 to 2025
$499k
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA257814NCI NIH HHS T32 CA261856NIDCR NIH HHS R01 DE028290NIDCR NIH HHS R03 DE033550
6 · The paper itself

Abstract

Magnetic resonance (MR)-guided radiation therapy (RT) is enhancing head and neck cancer (HNC) treatment through superior soft tissue contrast and longitudinal imaging capabilities. However, manual tumor segmentation remains a significant challenge, spurring interest in artificial intelligence (AI)-driven automation. To accelerate innovation in this field, we present the Head and Neck Tumor Segmentation for MR-Guided Applications (HNTS-MRG) 2024 Challenge, a satellite event of the 27th International Conference on Medical Image Computing and Computer Assisted Intervention. This challenge addresses the scarcity of large, publicly available AI-ready adaptive RT datasets in HNC and explores the potential of incorporating multi-timepoint data to enhance RT auto-segmentation performance. Participants tackled two HNC segmentation tasks: automatic delineation of primary gross tumor volume (GTVp) and gross metastatic regional lymph nodes (GTVn) on pre-RT (Task 1) and mid-RT (Task 2) T2-weighted scans. The challenge provided 150 HNC cases for training and 50 for final testing hosted on grand-challenge.org using a Docker submission framework. In total, 19 independent teams from across the world qualified by submitting both their algorithms and corresponding papers, resulting in 18 submissions for Task 1 and 15 submissions for Task 2. Evaluation using the mean aggregated Dice Similarity Coefficient showed top-performing AI methods achieved scores of 0.825 in Task 1 and 0.733 in Task 2. These results surpassed clinician interobserver variability benchmarks, marking significant strides in automated tumor segmentation for MR-guided RT applications in HNC.

Indexed as

artificial intelligencecontouringdata challengedeep learningHead and neck cancerimage-guidedmagnetic resonance imagingradiotherapysegmentation

Identifiers

PMID40115167
PMCPMC11925392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.